In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras–effector interaction

Mutational activation of the Ras oncogene products (H-Ras, K-Ras, and N-Ras) is frequently observed in human cancers, making them promising anticancer drug targets. Nonetheless, no effective strategy has been available for the development of Ras inhibitors, partly owing to the absence of well-define...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Shima, Fumi, Yoshikawa, Yoko, Ye, Min, Araki, Mitsugu, Matsumoto, Shigeyuki, Liao, Jingling, Hu, Lizhi, Sugimoto, Takeshi, Ijiri, Yuichi, Takeda, Azusa, Nishiyama, Yuko, Sato, Chie, Muraoka, Shin, Tamura, Atsuo, Osoda, Tsutomu, Tsuda, Ken-ichiro, Miyakawa, Tomoya, Fukunishi, Hiroaki, Shimada, Jiro, Kumasaka, Takashi, Yamamoto, Masaki, Kataoka, Tohru
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2013
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3657810/
https://ncbi.nlm.nih.gov/pubmed/23630290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1217730110
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak